• Activity INFORMATION

  Overview

  Cabotegravir and lenacapravir are two antiretroviral drugs used in the treatment of HIV infection. During the webinar, pharmacists and nurses will be educated on the mechanism of action, pharmacokinetics, and administration of these drugs. The speakers will also discuss the appropriate patient population for use, potential adverse effects, and drug interactions. The webinar will emphasize the importance of monitoring patients receiving cabotegravir and lenacapravir and the role of pharmacists and nurses in ensuring safe and effective use of these drugs.
  

  Handouts

  • Slide Document :   23187H02_2pp.pdf Download

  • Slide Document :   23187H02_6pp.pdf Download

  Financial Support By

  PharmCon

• Learning OBJECTIVES

  Pharmacist

  Identify the appropriate patient population for use, potential adverse effects, and drug interactions associated with cabotegravir and lenacapravir

  Describe the pharmacokinetics of cabotegravir and lenacapravir in the treatment of HIV

  Evaluate the importance of monitoring patients receiving cabotegravir and lenacapravir and the role of pharmacists in ensuring safe and effective use of these drugs

  Nurse

  Identify the appropriate patient population for use, potential adverse effects, and drug interactions associated with cabotegravir and lenacapravir

  Describe the pharmacokinetics of cabotegravir and lenacapravir in the treatment of HIV

  Evaluate the importance of monitoring patients receiving cabotegravir and lenacapravir and the role of pharmacists in ensuring safe and effective use of these drugs

• Activity ACCREDITATION

  Activity Type

  Knowledge

  CE Broker

  20-1161936

  Universal Activity Number

  Pharmacist 0798-0000-23-187-H02-P
  Nurse 0798-0000-23-187-H02-N
  

  PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

  PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

  In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.

• Activity INSTRUCTION

  Faculty

  Christina  O'Connor, PharmD, BCPS, AAHIV-P Medication Management Services Pharmacist, Infectious Diseases Clinic, Mayo Clinic Rochester

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).